Zacks Research Has Bullish Forecast for UNH Q2 Earnings

UnitedHealth Group Incorporated (NYSE:UNH) – Equities researchers at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for UnitedHealth Group in a report released on Thursday, January 30th. Zacks Research analyst D. Chatterjee now anticipates that the healthcare conglomerate will earn $7.33 per share for the quarter, up from their previous estimate of $7.00. The consensus estimate for UnitedHealth Group’s current full-year earnings is $29.63 per share. Zacks Research also issued estimates for UnitedHealth Group’s FY2025 earnings at $29.54 EPS, Q1 2026 earnings at $7.24 EPS, Q2 2026 earnings at $7.62 EPS, FY2026 earnings at $33.39 EPS and FY2027 earnings at $37.72 EPS.

Several other equities research analysts have also recently commented on UNH. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday, January 10th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. UBS Group cut their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. TD Cowen increased their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $545.08 on Monday. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a 50 day simple moving average of $535.03 and a 200-day simple moving average of $565.09. The stock has a market capitalization of $501.63 billion, a PE ratio of 35.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 earnings per share.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter worth about $27,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $30,000. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $32,000. Quarry LP raised its holdings in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.